Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Pediatr ; 158(2): 301-6, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20846670

RESUMEN

OBJECTIVE: To comprehensively assess auditory impairments in velocardiofacial syndrome (VCFS) and Williams syndrome (WS). STUDY DESIGN: Audiologic measurements were conducted with 62 subjects with VCFS and 44 subjects with WS, as well as two control groups consisting of 22 subjects with idiopathic developmental disability and 23 typically developing controls. An association between severity of hearing loss in VCFS and the (158)Val/Met polymorphism of the catechol-O-methyltransferase gene (COMT) was explored. RESULTS: Hearing was significantly more impaired in the VCFS and WS groups compared with the developmental disability and typically developing groups. Audiologic abnormalities identified in both the VCFS and WS groups included high-tone hearing loss (predominantly sensorineural or mixed type), loss of acoustic reflex, and middle ear pathologies. In both the VCFS and WS groups, hearing loss severity was positively correlated with age. In the VCFS group, hearing loss was more severe in the subgroup carrying the COMT Val allele compared with the subgroup carrying the COMT Met allele. CONCLUSIONS: Hearing impairments, including sensorineural hearing loss and acoustic reflex dysfunction, are very common in both VCFS and WS. Hearing loss is less severe in subjects with the COMT Met allele, possibly due to the protective effect of dopamine on the hearing system.


Asunto(s)
Cromosomas Humanos Par 7/genética , Síndrome de DiGeorge/genética , Pérdida Auditiva/genética , Síndrome de Williams/genética , Análisis de Varianza , Audiometría de Tonos Puros , Umbral Auditivo , Estudios de Casos y Controles , Niño , Preescolar , Deleción Cromosómica , Cromosomas Humanos Par 22 , Síndrome de DiGeorge/diagnóstico , Síndrome de DiGeorge/epidemiología , Femenino , Estudios de Seguimiento , Pérdida Auditiva/diagnóstico , Pérdida Auditiva/epidemiología , Pérdida Auditiva Conductiva/diagnóstico , Pérdida Auditiva Conductiva/epidemiología , Pérdida Auditiva Conductiva/genética , Pérdida Auditiva Sensorineural/diagnóstico , Pérdida Auditiva Sensorineural/epidemiología , Pérdida Auditiva Sensorineural/genética , Humanos , Incidencia , Lactante , Masculino , Índice de Severidad de la Enfermedad , Síndrome de Williams/diagnóstico , Síndrome de Williams/epidemiología
2.
J Neurosurg Spine ; 3(3): 173-81, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16235699

RESUMEN

OBJECT: A Phase I, open-label nonrandomized study was conducted to assess the safety and tolerability of incubated autologous macrophages administered to patients with acute complete spinal cord injury (SCI). METHODS: This therapy was first tested in rat models of spinal cord transection and contusion, in which it was shown to promote motor recovery. The procedure developed for clinical use consists of isolating monocytes from patient blood and incubating them ex vivo with autologous dermis. The resulting incubated autologous macrophages were injected into the patient's spinal cord immediately caudal to the lesion within 14 days of injury. Patients underwent preoperative and follow-up neurological assessment (American Spinal Injury Association [ASIA] standards), electrophysiological monitoring (motor evoked and/or somatosensory evoked potentials), magnetic resonance imaging, and safety monitoring. Before macrophage administration, complete neurological functional loss (ASIA Grade A) was confirmed in all patients. Of the eight patients in the study, three recovered clinically significant neurological motor and sensory function (ASIA Grade C status). During the study period, some adverse events were encountered, the most serious of which involved two cases of pulmonary embolism and one case of osteomyelitis that were treated and resolved without further complication. These and other adverse events appear to be similar to those encountered in other spinal cord-injured patients and are not considered a consequence of the experimental therapy. CONCLUSIONS: It is concluded that incubated autologous macrophage cell therapy is well tolerated in patients with acute SCI. Further clinical evaluation is warranted.


Asunto(s)
Inmunoterapia/métodos , Macrófagos/inmunología , Traumatismos de la Médula Espinal/terapia , Enfermedad Aguda , Adulto , Técnicas de Cultivo de Célula , Potenciales Evocados , Femenino , Humanos , Masculino , Embolia Pulmonar/etiología , Traumatismos de la Médula Espinal/patología , Trasplante Autólogo , Resultado del Tratamiento
3.
Psychophysiology ; 52(6): 782-9, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25603839

RESUMEN

The neurophysiologic aberrations underlying the auditory hypersensitivity in Williams syndrome (WS) are not well defined. The P1-N1-P2 obligatory complex and mismatch negativity (MMN) response were investigated in 18 participants with WS, and the results were compared with those of 18 age- and gender-matched typically developing (TD) controls. Results revealed significantly higher amplitudes of both the P1-N1-P2 obligatory complex and the MMN response in the WS participants than in the TD controls. The P1-N1-P2 complex showed an age-dependent reduction in the TD but not in the WS participants. Moreover, high P1-N1-P2 complex was associated with low verbal comprehension scores in WS. This investigation demonstrates that central auditory processing is hyperactive in WS. The increase in auditory brain responses of both the obligatory complex and MMN response suggests aberrant processes of auditory encoding and discrimination in WS. Results also imply that auditory processing may be subjected to a delayed or diverse maturation and may affect the development of high cognitive functioning in WS.


Asunto(s)
Corteza Auditiva/fisiopatología , Potenciales Evocados Auditivos/fisiología , Síndrome de Williams/fisiopatología , Estimulación Acústica , Adolescente , Adulto , Niño , Electroencefalografía , Femenino , Humanos , Masculino , Tiempo de Reacción/fisiología , Adulto Joven
4.
J Psychiatr Res ; 47(11): 1623-9, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23910792

RESUMEN

22q11.2 deletion syndrome (22q11.2DS) is a common genetic risk factor for the development of schizophrenia. We investigated two neurophysiological endophenotypes of schizophrenia - P50 sensory gating and mismatch negativity in 22q11.2DS subject and evaluated their association with catechol O-methyltransferase (COMT) and proline dehydrogenase (PRODH) genetic variants. We also assessed the association of neurophysiological measures with schizophrenia-like symptomatology in 22q11.2DS. Fifty-nine subjects, 41 with 22q11.2DS and 18 typically developing controls, participated in the study. The participants with 22q11.2DS were genotyped for the COMT Val(158)Met (rs4680) and PRODH Gln(19)Pro (rs2008720) and Arg(185)Trp (rs4819756) polymorphisms. Following psychiatric evaluation, all the participants underwent neurophysiological recordings and executive function assessment. The 22q11.2DS group showed poorer sensory gating of the P50 response than the controls. Within the 22q11.2DS group, the COMT Met allele was associated with poorer sensory gating, while both the COMT Met allele and the PRODH Pro-Arg haplotype were associated with smaller mismatch negativity amplitudes. Smaller mismatch negativity amplitudes predicted greater impairment of executive functions and greater severity of schizophrenia-like negative symptoms in 22q11.2DS. The current study demonstrates that sensory gating impairments that are typical of schizophrenia are found in 22q11.2DS subjects. Our results further suggest that COMT and PRODH genetic variations contribute to sensory gating and mismatch negativity schizophrenia-like impairments in 22q11.2DS, possibly via dopaminergic/glutamatergic networks. The associations of mismatch negativity impairments with increased severity of schizophrenia-like negative symptoms and poorer executive functions performance in our 22q11.2DS sample suggest that mismatch negativity is a potential endophenotype for schizophrenia in 22q11.2DS.


Asunto(s)
Síndrome de Deleción 22q11/genética , Síndrome de Deleción 22q11/fisiopatología , Catecol O-Metiltransferasa/genética , Polimorfismo de Nucleótido Simple/genética , Prolina Oxidasa/genética , Esquizofrenia/fisiopatología , Estimulación Acústica , Adolescente , Adulto , Niño , Variación Contingente Negativa/genética , Endofenotipos , Femenino , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , Filtrado Sensorial/genética , Adulto Joven
5.
Cochlear Implants Int ; 13(1): 26-34, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22340749

RESUMEN

OBJECTIVES: The aims of this study were to collect data on electrically evoked compound action potential (eCAP) and electrically evoked stapedius reflex thresholds (eSRT) in HiResolution(TM) cochlear implant (CI) users, and to explore the relationships between these objective measures and behavioural measures of comfort levels (M-levels). METHODS: A prospective study on newly implanted subjects was designed. The eCAP was measured intra-operatively and at first fitting through neural response imaging (NRI), using the SoundWave(TM) fitting software. The eSRT was measured intra-operatively by visual monitoring of the stapes, using both single-electrode stimulation and speech bursts (four electrodes stimulated at the same time). Measures of M-levels were performed according to standard clinical practice and collected at first fitting, 3 and 6 months of CI use. RESULTS: One hundred seventeen subjects from 14 centres, all implanted unilaterally with a HiResolution CII Bionic Ear(®) or HiRes 90K(®), were included in the study. Speech burst stimulation elicited a significantly higher eSRT success rate than single-electrode stimulation, 84 vs. 64% respectively. The NRI success rate was 81% intra-operatively, significantly increasing to 96% after 6 months. Fitting guidelines were defined on the basis of a single NRI measurement. Correlations, analysis of variance, and multiple regression analysis were applied to generate a predictive model for the M-levels. DISCUSSION: Useful insights were produced into the behaviour of objective measures according to time, electrode location, and fitting parameters. They may usefully assist in programming the CI when no reliable feedback is obtained through standard behavioural procedures.


Asunto(s)
Potenciales de Acción/fisiología , Implantación Coclear/métodos , Implantes Cocleares , Diagnóstico por Imagen/métodos , Potenciales Evocados Auditivos , Reflejo Acústico/fisiología , Estapedio , Adolescente , Adulto , Anciano , Análisis de Varianza , Umbral Auditivo , Niño , Estudios de Cohortes , Sordera/diagnóstico , Sordera/cirugía , Estimulación Eléctrica/métodos , Femenino , Humanos , Percepción Sonora , Masculino , Persona de Mediana Edad , Monitoreo Intraoperatorio , Análisis Multivariante , Cuidados Posoperatorios/métodos , Valor Predictivo de las Pruebas , Pronóstico , Estudios Prospectivos , Análisis de Regresión , Programas Informáticos , Percepción del Habla , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA